Skip to main navigation
Skip to search
Skip to main content
University of Birmingham Home
Help & FAQ
Home
Research output
Profiles
Research units
Projects
Activities
Datasets
Equipment
Prizes
Press/Media
Search by expertise, name or affiliation
Antithrombotic therapy in hypertension: a Cochrane Systematic review
DC Felmeden,
Gregory Lip
Sport, Exercise and Rehabilitation Sciences
Cardiovascular Sciences
Research output
:
Contribution to journal
›
Article
19
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Antithrombotic therapy in hypertension: a Cochrane Systematic review'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Hypertension
100%
Elevated Blood Pressure
100%
Antithrombotic Therapy
100%
Cochrane Systematic Review
100%
Placebo
44%
Antiplatelet Therapy
44%
Acetylsalicylic Acid
44%
Active Treatment
33%
Primary Prevention
22%
Myocardial Infarction
22%
Thrombosis
22%
Secondary Prevention
22%
Total Mortality
22%
Major Haemorrhage
22%
Cardiovascular Disease
11%
All-cause Mortality
11%
Meta-analysis
11%
Blood Pressure
11%
Aspirin
11%
Anticoagulation
11%
Cardiovascular Mortality
11%
Hypertension Complications
11%
Associated Complications
11%
Warfarin
11%
Cardiovascular Events
11%
Coronary Events
11%
Large Trials
11%
Oral Anticoagulants
11%
Stroke Event
11%
Vascular Events
11%
Antiplatelet Agents
11%
Clopidogrel
11%
Absolute Reductions
11%
Systemic Blood Pressure
11%
Thrombotic Events
11%
Absolute Benefit
11%
Small Clinical Trials
11%
Glycoprotein IIb/IIIa Inhibitors
11%
Warfarin Therapy
11%
Intravascular Pressure
11%
Ticlopidine
11%
Medicine and Dentistry
Systematic Review
100%
Elevated Blood Pressure
100%
Antithrombotic Therapy
100%
Acetylsalicylic Acid
55%
Placebo
44%
Antiplatelet
44%
Blood Pressure
33%
Bleeding
33%
Myocardial Infarction
22%
Apoplexy
22%
Thrombosis
22%
Primary Prevention
22%
Secondary Prevention
22%
Warfarin
22%
Cardiovascular System
11%
Cardiovascular Disease
11%
Meta-Analysis
11%
All Cause Mortality
11%
Anticoagulation
11%
Cardiovascular Mortality
11%
Thromboembolism
11%
Antithrombotic
11%
Antiplatelet Drug
11%
Clopidogrel
11%
Glycoprotein IIb/IIIa Inhibitors
11%
Ticlopidine
11%
Pharmacology, Toxicology and Pharmaceutical Science
Antithrombotic Therapy
100%
Elevated Blood Pressure
100%
Acetylsalicylic Acid
55%
Placebo
44%
Antiplatelet
44%
Bleeding
33%
Heart Infarction
22%
Cerebrovascular Accident
22%
Thrombosis
22%
Warfarin
22%
All Cause Mortality
11%
Cardiovascular Disease
11%
Cardiovascular Mortality
11%
Thromboembolism
11%
Anticoagulant Agent
11%
Antithrombocytic Agent
11%
Clopidogrel
11%
Fibrinogen Receptor
11%
Ticlopidine
11%
Neuroscience
Antithrombotic
100%
Hypertension
100%
Placebo
80%
Cerebrovascular Accident
40%
Myocardial Infarction
40%
Warfarin
40%
Meta-Analysis
20%
Aspirin
20%
Antiplatelet Drug
20%
Ticlopidine
20%
Glycoprotein IIb/IIIa Inhibitors
20%
Clopidogrel
20%